Plain-English translation of NCT04389437 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are studying whether advanced eye imaging techniques can detect early signs of memory and thinking disorders like Alzheimer's disease and Parkinson's dementia. The study uses two specialized eye scans — called optical coherence tomography angiography (OCT-A) and adaptive optics — to look at the tiny blood vessels and structure of the retina (back of the eye). These scans are completely non-invasive and painless, and researchers believe they may reveal patterns that could help identify these conditions earlier.
Recent studies suggest that people with memory disorders often have changes in the blood vessels at the back of their eyes, but no one has thoroughly studied this using the newest imaging technology. If this treatment can reliably detect these eye changes, it could become a simple, quick way to help doctors identify memory disorders in their earliest stages.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will have your eyes scanned using two advanced imaging machines — both are quick, painless, and non-invasive. The scans take pictures of the tiny blood vessels and structure at the back of your eye. You may also have standard memory and thinking tests and possibly an MRI scan of your brain. The entire visit typically takes a few hours, and you should expect one main visit, though researchers may ask for follow-up information.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
France